NGI226 clinical trials

A two part, randomized, participant and investigator-blinded, 2-arm, parallel-design, placebo-controlled study to evaluate the safety, tolerability and preliminary efficacy of NGI226 microparticles on tendon regeneration in patients with Achilles tendinopathy

This study is looking into a new treatment called NGI226 for Achilles tendinopathy, a painful heel condition. We want to see if it's safe, how well people tolerate it, and if it helps regenerate tendons. It's an early-stage study.